Live Breaking News & Updates on நேரம் சியாங்

Stay updated with breaking news from நேரம் சியாங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Transcript


Operator
3Greetings. Welcome to the Amphastar Pharmaceuticals Inc. First Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].
All statements on this conference call that are not historical are forward-looking statements, including, among other things, statements relating to our expectations regarding future financial performance, backlog, sales and marketing of our products, market size and growth, product development, the timing of FDA filings or approvals, including the DMF of AMP, the timing of product launches, acquisitions and other matters related to our pipeline of product candidates, our share buyback program and other future events, such as the impact of the COVID-19 pandemic and related responses of business and governments to the pandemic on our operations and personnel, and on commercial activity and demand across our business operations, and ....

Raymond James , Tony Marrs , Evan Hua , Lucas Lee , David Steinberg , Gary Mcmahon , Tim Chiang Northland , Tim Chiang , Serge Belanger , Dan Dischner , Piper Sandler , David Amsellem , David Amsellem Piper Sandler , Serge Belanger Needham , Elliot Wilbur , Lucas Lee Raymond James , David Steinberg Jefferies , Exchange Commission , Vp Corporate Communications , Corporate Communications , Regulatory Affairs , Amphastar Pharmaceuticals Inc , Company Analyst , Amphastar Pharmaceuticals , First Quarter Earnings , Annual Report ,

Biodelivery Sciences International Inc (BDSI) Q4 2020 Earnings Call Transcript


Operator
Greetings, and welcome to the BioDelivery Sciences Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. Please go ahead.
Terry Coelho
Executive Vice President and Chief Financial Officer
Thank you, and good morning, everyone. Welcome to our fourth quarter 2020 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott Plesha, President and Chief Commercial Officer. Following our prepared remarks, we will conduct a question-and-answer session. Earlier today BioDelivery Sciences issued a press release announcing its financial results for the fourth quarter and full year 2020. A copy of the release can be found on the Investor Relations page of the comp ....

United States , Terry Coelho , Brandon Folkes Cantor Fitzgerald , Tim Chiang Northland , Tim Chiang , Jeff Bailey , Tim Lugo William Blair , Scott Plesha , Piper Sandler , Gregg Gilbert , Tim Lugo , Scott Henry , David Amsellem , Jeffreya Bailey , David Amsellem Piper Sandler , Gregg Gilbert Truist , Brandon Folkes , William Blair , Biodelivery Sciences , Biodelivery Sciences Fourth Quarter , Cantor Fitzgerald , Biodelivery Sciences International Inc , Full Year , Executive Vice President , Chief Financial , Vice President ,

VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript


VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
VYNE Therapeutics Inc. (NASDAQ: VYNE)
Q4 2020 Earnings Call
Good morning and welcome to the VYNE Therapeutics conference call to discuss the fourth-quarter and full-year 2020 financial results and update. [Operator instructions] Following the company s formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company s request. I will now turn the call over to Michael Wood of LifeSci Advisors.
Please go ahead.
LifeSci Advisors Managing Director
Good morning, everyone, and thanking thank you for joining us this morning. Before we begin with formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve r ....

United States , Oren Livnat , Iain Stuart , Balaji Prasad Barclays , Matt Wiley , Balaji Prasad , Tim Chiang Northland , Carvey Leung Cantor Fitzgerald , Tim Chiang , Michael Wood Lifesci , Piper Sandler , Patrick Dolezal Lifesci , Patrick Dolezal , Louise Chen , Dave Domzalski , Michael Wood , David Amsellem , David Amsellem Piper Sandler , Andrew Saik , Therapeutics Inc , Cantor Fitzgerald , National Preferred Formularies , Oren Livnat Hc Wainwright Co , Motley Fool , Call Transcript , Motley Fool Logo ,